ctrl K

Price Alert

Lipella Pharmaceuticals I... (LIPO)

NASDAQ: LIPO · Real-Time Price · USD

0.64

0.00 (0.05%)

At close: Aug 15, 2025, 2:41 PM

0.64

0.00%

After-hours: Aug 15, 2025, 02:41 PM EDT

Lipella Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	2.18M	3.29M	5.12M	1.41M
Short-Term Investments	n/a	n/a	n/a	300.55K
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	-150.82K	-204.8K
Receivables	84.71K	32.29K	113.66K	n/a
Inventory	n/a	n/a	-113.66K	n/a
Other Current Assets	n/a	n/a	n/a	n/a
Total Current Assets	2.62M	3.43M	5.8M	1.81M
Property-Plant & Equipment	56.62K	147.89K	150.82K	204.8K
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	56.62K	147.89K	150.82K	204.8K
Total Assets	2.67M	3.58M	5.95M	2.01M
Account Payables	388.19K	138.02K	384.36K	46.9K
Deferred Revenue	n/a	n/a	n/a	178.97K
Short-Term Debt	47.6K	n/a	275K	25K
Other Current Liabilities	n/a	n/a	n/a	-357.93K
Total Current Liabilities	754.42K	385.36K	1.18M	340.63K
Long-Term Debt	n/a	n/a	n/a	50K
Other Long-Term Liabilities	n/a	n/a	n/a	30.35K
Total Long-Term Liabilities	n/a	47.37K	96.26K	248.71K
Total Liabilities	754.42K	432.73K	1.27M	589.34K
Total Debt	47.6K	136.59K	429.52K	282.96K
Common Stock	121.00	605.00	574.00	967.00
Retained Earnings	-15.34M	-10.32M	-5.7M	-3.11M
Comprehensive Income	n/a	n/a	n/a	-3.11M
Shareholders Equity	1.92M	3.14M	4.68M	1.42M
Total Investments	n/a	n/a	n/a	300.55K